Cargando…

Increased expression of cystine/glutamate antiporter in multiple sclerosis

BACKGROUND: Glutamate excitotoxicity contributes to oligodendrocyte and tissue damage in multiple sclerosis (MS). Intriguingly, glutamate level in plasma and cerebrospinal fluid of MS patients is elevated, a feature which may be related to the pathophysiology of this disease. In addition to glutamat...

Descripción completa

Detalles Bibliográficos
Autores principales: Pampliega, Olatz, Domercq, María, Soria, Federico N, Villoslada, Pablo, Rodríguez-Antigüedad, Alfredo, Matute, Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3117706/
https://www.ncbi.nlm.nih.gov/pubmed/21639880
http://dx.doi.org/10.1186/1742-2094-8-63
_version_ 1782206356659372032
author Pampliega, Olatz
Domercq, María
Soria, Federico N
Villoslada, Pablo
Rodríguez-Antigüedad, Alfredo
Matute, Carlos
author_facet Pampliega, Olatz
Domercq, María
Soria, Federico N
Villoslada, Pablo
Rodríguez-Antigüedad, Alfredo
Matute, Carlos
author_sort Pampliega, Olatz
collection PubMed
description BACKGROUND: Glutamate excitotoxicity contributes to oligodendrocyte and tissue damage in multiple sclerosis (MS). Intriguingly, glutamate level in plasma and cerebrospinal fluid of MS patients is elevated, a feature which may be related to the pathophysiology of this disease. In addition to glutamate transporters, levels of extracellular glutamate are controlled by cystine/glutamate antiporter x(c)(-), an exchanger that provides intracellular cystine for production of glutathione, the major cellular antioxidant. The objective of this study was to analyze the role of the system x(c)(- )in glutamate homeostasis alterations in MS pathology. METHODS: Primary cultures of human monocytes and the cell line U-937 were used to investigate the mechanism of glutamate release. Expression of cystine glutamate exchanger (xCT) was quantified by quantitative PCR, Western blot, flow cytometry and immunohistochemistry in monocytes in vitro, in animals with experimental autoimmune encephalomyelitis (EAE), the animal model of MS, and in samples of MS patients. RESULTS AND DISCUSSION: We show here that human activated monocytes release glutamate through cystine/glutamate antiporter x(c)(- )and that the expression of the catalytic subunit xCT is upregulated as a consequence of monocyte activation. In addition, xCT expression is also increased in EAE and in the disease proper. In the later, high expression of xCT occurs both in the central nervous system (CNS) and in peripheral blood cells. In particular, cells from monocyte-macrophage-microglia lineage have higher xCT expression in MS and in EAE, indicating that immune activation upregulates xCT levels, which may result in higher glutamate release and contribution to excitotoxic damage to oligodendrocytes. CONCLUSIONS: Together, these results reveal that increased expression of the cystine/glutamate antiporter system x(c)(- )in MS provides a link between inflammation and excitotoxicity in demyelinating diseases.
format Online
Article
Text
id pubmed-3117706
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31177062011-06-18 Increased expression of cystine/glutamate antiporter in multiple sclerosis Pampliega, Olatz Domercq, María Soria, Federico N Villoslada, Pablo Rodríguez-Antigüedad, Alfredo Matute, Carlos J Neuroinflammation Research BACKGROUND: Glutamate excitotoxicity contributes to oligodendrocyte and tissue damage in multiple sclerosis (MS). Intriguingly, glutamate level in plasma and cerebrospinal fluid of MS patients is elevated, a feature which may be related to the pathophysiology of this disease. In addition to glutamate transporters, levels of extracellular glutamate are controlled by cystine/glutamate antiporter x(c)(-), an exchanger that provides intracellular cystine for production of glutathione, the major cellular antioxidant. The objective of this study was to analyze the role of the system x(c)(- )in glutamate homeostasis alterations in MS pathology. METHODS: Primary cultures of human monocytes and the cell line U-937 were used to investigate the mechanism of glutamate release. Expression of cystine glutamate exchanger (xCT) was quantified by quantitative PCR, Western blot, flow cytometry and immunohistochemistry in monocytes in vitro, in animals with experimental autoimmune encephalomyelitis (EAE), the animal model of MS, and in samples of MS patients. RESULTS AND DISCUSSION: We show here that human activated monocytes release glutamate through cystine/glutamate antiporter x(c)(- )and that the expression of the catalytic subunit xCT is upregulated as a consequence of monocyte activation. In addition, xCT expression is also increased in EAE and in the disease proper. In the later, high expression of xCT occurs both in the central nervous system (CNS) and in peripheral blood cells. In particular, cells from monocyte-macrophage-microglia lineage have higher xCT expression in MS and in EAE, indicating that immune activation upregulates xCT levels, which may result in higher glutamate release and contribution to excitotoxic damage to oligodendrocytes. CONCLUSIONS: Together, these results reveal that increased expression of the cystine/glutamate antiporter system x(c)(- )in MS provides a link between inflammation and excitotoxicity in demyelinating diseases. BioMed Central 2011-06-03 /pmc/articles/PMC3117706/ /pubmed/21639880 http://dx.doi.org/10.1186/1742-2094-8-63 Text en Copyright ©2011 Pampliega et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Pampliega, Olatz
Domercq, María
Soria, Federico N
Villoslada, Pablo
Rodríguez-Antigüedad, Alfredo
Matute, Carlos
Increased expression of cystine/glutamate antiporter in multiple sclerosis
title Increased expression of cystine/glutamate antiporter in multiple sclerosis
title_full Increased expression of cystine/glutamate antiporter in multiple sclerosis
title_fullStr Increased expression of cystine/glutamate antiporter in multiple sclerosis
title_full_unstemmed Increased expression of cystine/glutamate antiporter in multiple sclerosis
title_short Increased expression of cystine/glutamate antiporter in multiple sclerosis
title_sort increased expression of cystine/glutamate antiporter in multiple sclerosis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3117706/
https://www.ncbi.nlm.nih.gov/pubmed/21639880
http://dx.doi.org/10.1186/1742-2094-8-63
work_keys_str_mv AT pampliegaolatz increasedexpressionofcystineglutamateantiporterinmultiplesclerosis
AT domercqmaria increasedexpressionofcystineglutamateantiporterinmultiplesclerosis
AT soriafedericon increasedexpressionofcystineglutamateantiporterinmultiplesclerosis
AT villosladapablo increasedexpressionofcystineglutamateantiporterinmultiplesclerosis
AT rodriguezantiguedadalfredo increasedexpressionofcystineglutamateantiporterinmultiplesclerosis
AT matutecarlos increasedexpressionofcystineglutamateantiporterinmultiplesclerosis